Selek U - Search Results

1

Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial.

Wang XS, Rhines LD, Shiu AS, Yang JN, Selek U, Gning I, Liu P, Allen PK, Azeem SS, Brown PD, Sharp HJ, Weksberg DC, Cleeland CS, Chang EL. Wang XS, et al. Among authors: selek u. Lancet Oncol. 2012 Apr;13(4):395-402. doi: 10.1016/S1470-2045(11)70384-9. Epub 2012 Jan 27. Lancet Oncol. 2012. PMID: 22285199 Free PMC article. Clinical Trial.

2

In Reference to Difficult Tracheal Intubation and Airway Outcomes After Radiation for Nasopharyngeal Carcinoma.

Somay E, Topkan E, Selek U. Somay E, et al. Among authors: selek u. Laryngoscope. 2023 Dec;133(12):E67. doi: 10.1002/lary.30948. Epub 2023 Aug 9. Laryngoscope. 2023. PMID: 37555641 No abstract available.

3

Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy.

Pehlivan UA, Somay E, Yilmaz B, Besen AA, Mertsoylu H, Selek U, Topkan E. Pehlivan UA, et al. Among authors: selek u. J Clin Med. 2023 Oct 30;12(21):6863. doi: 10.3390/jcm12216863. J Clin Med. 2023. PMID: 37959329 Free PMC article.

4

Comment on: A survey on oral health-related standard of care for head and neck cancer patients in the EU.

Somay E, Topkan E, Selek U. Somay E, et al. Among authors: selek u. Oral Dis. 2024 Jul;30(5):3536-3537. doi: 10.1111/odi.14787. Epub 2023 Oct 23. Oral Dis. 2024. PMID: 37870103 No abstract available.

5

Comment on "Predictors of prolonged treatment time intervals in oral cavity cancer".

Topkan E, Somay E, Selek U. Topkan E, et al. Among authors: selek u. Oral Oncol. 2024 Jan;148:106652. doi: 10.1016/j.oraloncology.2023.106652. Epub 2023 Dec 2. Oral Oncol. 2024. PMID: 38043183 No abstract available.

6

Comment on: Diosgenin prevents periodontitis by inhibiting inflammation and promoting osteogenic differentiation.

Topkan E, Somay E, Selek U. Topkan E, et al. Among authors: selek u. Oral Dis. 2024 Jul;30(5):3538-3539. doi: 10.1111/odi.14788. Epub 2023 Oct 23. Oral Dis. 2024. PMID: 37870099 No abstract available.

7

Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.

Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U. Yilmaz B, et al. Among authors: selek u. Strahlenther Onkol. 2023 Oct;199(10):910-921. doi: 10.1007/s00066-023-02119-0. Epub 2023 Aug 11. Strahlenther Onkol. 2023. PMID: 37566126

8

Comment on: Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.

Somay E, Topkan E, Selek U. Somay E, et al. Among authors: selek u. Pediatr Blood Cancer. 2024 Apr;71(4):e30870. doi: 10.1002/pbc.30870. Epub 2024 Jan 12. Pediatr Blood Cancer. 2024. PMID: 38217076 No abstract available.

9

Letter to the Editor: Radiotherapy Increases aMMP-8 Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study.

Yilmaz B, Topkan E, Pehlivan B, Selek U. Yilmaz B, et al. Among authors: selek u. Cancer Control. 2023 Jan-Dec;30:10732748231187276. doi: 10.1177/10732748231187276. Cancer Control. 2023. PMID: 37387460 Free PMC article. No abstract available.

10

Comment on: Evaluation of halitosis parameters in patients undergoing head and neck radiotherapy.

Somay E, Topkan E, Selek U. Somay E, et al. Among authors: selek u. Oral Dis. 2024 Jul;30(5):3514-3515. doi: 10.1111/odi.14665. Epub 2023 Jul 13. Oral Dis. 2024. PMID: 37448195 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters